Cilostazol in Acute Ischemic Stroke Treatment (CAIST Trial): a randomized double-blind non-inferiority trial. - Wikidata - wikimedia - TriplyDB

Cilostazol in Acute Ischemic Stroke Treatment (CAIST Trial): a randomized double-blind non-inferiority trial.

Cilostazol in Acute Ischemic Stroke Treatment (CAIST Trial): a randomized double-blind non-inferiority trial.

http://www.wikidata.org/entity/Q54432578

about

Oral antiplatelet therapy for acute ischaemic stroke Antiplatelet therapy for carotid artery stenting Antiplatelet regimens in the long-term secondary prevention of transient ischaemic attack and ischaemic stroke: an updated network meta-analysis Improved thrombolytic effect with focused ultrasound and neuroprotective agent against acute carotid artery thrombosis in rat.Research on intracranial atherosclerosis from the East and west: why are the results different?Quantification of errors in ordinal outcome scales using shannon entropy: effect on sample size calculations.The efficacy and safety of cilostazol for the secondary prevention of ischemic stroke in acute and chronic phases in Asian population--an updated meta-analysis.RETRACTED: Systematic study of cilostazol on secondary stroke prevention: a meta-analysis Nitric oxide: considerations for the treatment of ischemic stroke.Update on selecting and adjusting antiplatelet therapy for prevention of noncardiogenic, recurrent ischemic stroke.Use of cilostazol for secondary stroke prevention: an old dog with new tricks?The effectiveness and safety of triple-antiplatelet treatment based on cilostazol for patients receiving percutaneous coronary intervention: a meta-analysis.Clinical efficacy and safety of cilostazol: a critical review of the literature.Meta-Analysis of Studies Evaluating the Effect of Cilostazol on Major Outcomes After Carotid Stenting.Comparative Efficacy and Safety of Nine Anti-Platelet Therapies for Patients with Ischemic Stroke or Transient Ischemic Attack: a Mixed Treatment Comparisons.Cilostazol improves endothelial function in acute cerebral ischemia patients: a double-blind placebo controlled trial with flow-mediated dilation technique.Thrombectomy for delayed basilar stent occlusion with good outcome Clopidogrel loading dose versus maintenance dose to treat patients with acute ischaemic stroke in China (CLASS-China): results from a prospective double-blind randomised clinical trial.Preventing cognitive decline and dementia from cerebral small vessel disease: The LACI-1 Trial. Protocol and statistical analysis plan of a phase IIa dose escalation trial testing tolerability, safety and effect on intermediary endpoints of isosorbi Effect of cilostazol in the treatment of acute ischemic stroke in the lenticulostriate artery territory.Efficacy of cilostazol-based dual antiplatelet treatment in patients undergoing carotid artery stenting.Aspirin plus dipyridamole has the highest surface under the cumulative ranking curves (SUCRA) values in terms of mortality, intracranial hemorrhage, and adverse event rate among 7 drug therapies in the treatment of cerebral infarction.

P2860

Q24197866-F78B8A30-380D-49AE-AA55-3836FBA204C4 Q26852304-EE2A4ED2-95F6-4C71-BE34-9227AB597F7F Q28076042-E37AC390-CD19-40CA-9E23-0F89A6F2B3DF Q30356179-A5C4B91F-E4D2-4439-A6F9-F85439777B99 Q34357545-0DE10DD8-59BB-4A4E-9881-8442FA6EF0AB Q34826078-FC3507E7-F4F4-42B5-A9DA-C4EE444BC0C8 Q34995043-64472543-F8BB-4935-82ED-25A6B73F4C0B Q35061792-E336B965-15B4-46B3-B8C4-C1A0AA5D8784 Q36079329-625D6EAA-C4D6-44D4-B62F-31D18966DBB4 Q37943864-72F97D49-8A94-4371-89EB-AF4FAC717B4D Q37986922-72D0ECB1-FD7B-4ECF-8BE1-0F38CCF40E04 Q38010134-CDD19F37-E02E-4EDB-AB18-6F515980AA20 Q38372990-28E412E5-C532-46BB-9812-F85B2DB82AF9 Q38653643-4331ECD6-192D-4702-9529-4216A43D60ED Q40023249-D3BDEAEE-0BE7-4BEA-9DB0-47EF455B6866 Q41558315-1EAA40D8-9811-44AA-9E74-F2B65B03A4EA Q41954112-88B8946E-2B81-4EDF-8F23-BA9A863A799B Q42279148-21AB65AA-AE59-4EC6-95E5-1A132F726FB7 Q42690507-33EEE486-D32B-41C5-9BCD-15AB7DECD901 Q43914580-CB2F8BE0-FF10-4D38-9CAB-DF956DC4696F Q53118529-DA887D1A-F98C-4E27-8132-BABFF257CEFA Q55003714-CB473880-6D87-41E1-A9AD-D95032E59528

P2860

Cilostazol in Acute Ischemic Stroke Treatment (CAIST Trial): a randomized double-blind non-inferiority trial.

http://www.wikidata.org/entity/Q54432578

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

Cilostazol in Acute Ischemic S ...... e-blind non-inferiority trial.

@en

Cilostazol in Acute Ischemic Stroke Treatment

@nl

type

label

Cilostazol in Acute Ischemic S ...... e-blind non-inferiority trial.

@en

Cilostazol in Acute Ischemic Stroke Treatment

@nl

prefLabel

Cilostazol in Acute Ischemic S ...... e-blind non-inferiority trial.

@en

Cilostazol in Acute Ischemic Stroke Treatment

@nl

P1433

Q54432578-69876769-BAA6-4ABE-9EA4-9F76627CE34C

P1476

Q54432578-8AA00B8D-3F07-4D7A-829F-7DA003E7EF3E

P2093

Q54432578-036705E3-4A20-4088-8100-72DE3806B7E6

Q54432578-16EDB57E-93E7-420A-9CBB-18742F44D192

Q54432578-2421D33D-B48B-48B6-9356-5E318E228F0A

Q54432578-24B2937C-AF2A-4946-805E-EFF1EF4E9AD1

Q54432578-259731A9-7E2D-4288-B307-E0E41C1B13AD

Q54432578-61BCCB7F-891B-4CC9-84DF-2D2BB4195F3A

Q54432578-6B67ECA0-E7D9-42B2-8E80-E54BACC94533

Q54432578-6B94258D-5065-4F93-BF8C-D87DA2436AC3

Q54432578-7AC61265-70D2-4EC4-856A-0381E60F08F9

Q54432578-8C39DC63-8D16-4322-AF34-4A79A0459408

P2860

Q54432578-052597EA-6192-4281-BD19-99DDBD544F81

Q54432578-2E6F3300-97CE-45CE-BF19-A1B9AA5FE937

Q54432578-2F72C99E-3E49-435D-84F4-AECD279847BD

Q54432578-3A695927-9855-4525-B32F-E2DC27E7DD0E

Q54432578-5A595244-AC38-464C-AC49-C0065A2B6862

Q54432578-5B0801C7-56CA-47E0-A1FC-324CBA30804C

Q54432578-603DACC7-D867-4371-8505-9752533CB16A

Q54432578-62746E2F-311D-4874-93A6-D17AE9791A4F

Q54432578-63BCDB46-C594-49B2-841B-1B8B152B30BA

Q54432578-6E695E4B-502C-4010-A85C-638A3B59332A

P304

Q54432578-949B1FFD-148F-47F0-B0DA-FD453FF82B3A

P31

Q54432578-9052E42F-4D31-444B-BC5F-9B37C5BD08A0

P356

Q54432578-5FBF0AEC-854C-47D4-808B-FCDC71229FA7

P433

Q54432578-2029C5E7-1449-4639-AAE8-79B387F95E16

P478

Q54432578-F55229AE-4579-49C0-873A-DD93CA75D5B3

P50

Q54432578-80F0D9F5-FB74-425C-BD70-EEFFDC39FF1D

Q54432578-F3A4C480-20D4-4B5E-8ED2-E1CA0A49498B

P577

Q54432578-20D372BC-8E55-40AD-B14A-222631768531

P5875

Q54432578-E1D3A18F-C8F8-4276-8582-93F1B63EFCD0

P698

Q54432578-314F07D5-DB4B-4EDE-A38A-DECFC3505675

P356

P1433

Cerebrovascular Diseases

P1476

Cilostazol in Acute Ischemic S ...... e-blind non-inferiority trial.

@en

P2093

Byung-Chul Lee

http://www.w3.org/2001/XMLSchema#string

Dong-Eog Kim

http://www.w3.org/2001/XMLSchema#string

Hee-Joon Bae

http://www.w3.org/2001/XMLSchema#string

Jaseong Koo

http://www.w3.org/2001/XMLSchema#string

Jong S Kim

http://www.w3.org/2001/XMLSchema#string

Jong-Moo Park

http://www.w3.org/2001/XMLSchema#string

Joung-Ho Rha

http://www.w3.org/2001/XMLSchema#string

Ju-Hun Lee

http://www.w3.org/2001/XMLSchema#string

Kyung Bok Lee

http://www.w3.org/2001/XMLSchema#string

Kyungho Yu

http://www.w3.org/2001/XMLSchema#string

P2860

Aspirin resistance and atherothrombotic disease

A randomized crossover comparative study of aspirin, cilostazol and clopidogrel in normal controls: analysis with quantitative bleeding time and platelet aggregation test

Cilostazol prevents the progression of the symptomatic intracranial arterial stenosis: the multicenter double-blind placebo-controlled trial of cilostazol in symptomatic intracranial arterial stenosis

Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial

Guidelines for the Early Management of Adults With Ischemic Stroke

Comparing risks of death and recurrent vascular events between lacunar and non-lacunar infarction.

Transient ischemic attack: a dangerous Harbinger and an opportunity to intervene.

The vascular effects of cilostazol.

Antiplatelet therapy for secondary prevention of noncardioembolic ischemic stroke: a critical review.

Early treatment with aspirin plus extended-release dipyridamole for transient ischaemic attack or ischaemic stroke within 24 h of symptom onset (EARLY trial): a randomised, open-label, blinded-endpoint trial.

P304

65-71

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000327036

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-05-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51166417

http://www.w3.org/2001/XMLSchema#string

P698

21613787

http://www.w3.org/2001/XMLSchema#string